{"id":"NCT00968812","sponsor":"Janssen Research & Development, LLC","briefTitle":"CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride","officialTitle":"A Randomized, Double-Blind, 3-Arm Parallel-Group, 2-Year (104-Week), Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-28431754 Compared With Glimepiride in the Treatment of Subjects With Type 2 Diabetes Mellitus Not Optimally Controlled on Metformin Monotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09","primaryCompletion":"2011-12","completion":"2013-01","firstPosted":"2009-08-31","resultsPosted":"2013-06-04","lastUpdate":"2017-01-30"},"enrollment":1452,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Glimepiride","otherNames":["sulfonylurea"]},{"type":"DRUG","name":"Canagliflozin (JNJ-28431754)","otherNames":[]},{"type":"DRUG","name":"Metformin","otherNames":[]}],"arms":[{"label":"Glimepiride","type":"ACTIVE_COMPARATOR"},{"label":"Canagliflozin 100 mg","type":"EXPERIMENTAL"},{"label":"Canagliflozin 300 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to demonstrate the efficacy, safety, and tolerability of canagliflozin (JNJ-28431754) compared with glimepiride in patients with type 2 diabetes mellitus with inadequate control despite treatment with metformin.","primaryOutcome":{"measure":"Change in HbA1c From Baseline to Week 52","timeFrame":"Day 1 (Baseline) and Week 52","effectByArm":[{"arm":"Canagliflozin 100 mg","deltaMin":-0.82,"sd":0.039},{"arm":"Canagliflozin 300 mg","deltaMin":-0.93,"sd":0.039},{"arm":"Glimepiride","deltaMin":-0.81,"sd":0.039}],"pValues":[{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":138,"countries":["United States","Argentina","Bulgaria","Canada","Costa Rica","Denmark","Finland","Germany","India","Israel","Mexico","Norway","Philippines","Poland","Puerto Rico","Romania","Russia","Slovakia","South Korea","Ukraine"]},"refs":{"pmids":["38770818","31001673","29452178","27977934","27600862","27495291","27002421","26984361","26580237","26579834","25205142","24517339","23850055"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":24,"n":483},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Hypoglycaemia","Diarrhoea","Urinary tract infection"]}}